Drug Shortage Report for VAQTA
| Report ID | 100533 |
| Drug Identification Number | 02229702 |
| Brand name | VAQTA |
| Common or Proper name | hepatitis A vaccine, purified inactivated Suspension for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED |
| Strength(s) | 50UNIT |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 0.5ML 1DOSE VIAL |
| ATC code | J07BC |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-12-09 |
| Actual start date | 2019-12-10 |
| Estimated end date | 2020-12-31 |
| Actual end date | 2020-06-19 |
| Shortage status | Resolved |
| Updated date | 2020-06-20 |
| Company comments | Vaqta (Ped): Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2020-06-20 | English | Compare |
| v9 | 2020-06-19 | English | Compare |
| v8 | 2020-02-13 | French | Compare |
| v7 | 2020-02-13 | English | Compare |
| v6 | 2019-12-10 | English | Compare |
| v5 | 2019-12-10 | English | Compare |
| v4 | 2019-12-09 | French | Compare |
| v3 | 2019-12-09 | English | Compare |
| v2 | 2019-12-09 | French | Compare |
| v1 | 2019-12-09 | English | Compare |
Showing 1 to 10 of 10